Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

FDA Approves Priovant's LISRAYA (Brepocitinib) for Adult Dermatomyositis – First Oral Targeted JAK1/TYK2 Therapy in the Indication
CompanyDrug

FDA Approves Priovant’s LISRAYA (Brepocitinib) for Adult Dermatomyositis – First Oral Targeted JAK1/TYK2 Therapy in the Indication

The U.S. Food and Drug Administration (FDA) has approved LISRAYA (brepocitinib) 30 mg tablets, developed by Priovant Therapeutics (a Roivant Sciences / Pfizer venture), for the treatment of adult dermatomyositis…

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

Asymchem's Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Asymchem’s Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Hengrui Pharmaceuticals Gains NMPA Clearance for SHR-1316 (sc) in ES-SCLC Trial
CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Clearance for SHR-1316 (sc) in ES-SCLC Trial

Hansoh Pharma's Ameile Wins Fourth NMPA Approval for NSCLC Treatment
CompanyDrug

Hansoh Pharma’s Ameile Wins Fourth NMPA Approval for NSCLC Treatment

RemeGen's Disitamab Vedotin Receives NMPA Approval for HER2+ Breast Cancer with Liver Metastasis
CompanyDrug

RemeGen’s Disitamab Vedotin Receives NMPA Approval for HER2+ Breast Cancer with Liver Metastasis

Hengrui Pharma Files for New Dalpiciclib Indication in Early Breast Cancer
CompanyDrug

Hengrui Pharma Files for New Dalpiciclib Indication in Early Breast Cancer

AstraZeneca's Calquence Gains EU Approval for Mantle Cell Lymphoma
CompanyDrug

AstraZeneca’s Calquence Gains EU Approval for Mantle Cell Lymphoma

Huadong Medicine's HDM2005 Receives NMPA Approval for DLBCL Clinical Trial
CompanyDrug

Huadong Medicine’s HDM2005 Receives NMPA Approval for DLBCL Clinical Trial

Bayer AG Launches Phase I Study of 225Ac-GPC3 for Advanced Hepatocellular Carcinoma
CompanyDrug

Bayer AG Launches Phase I Study of 225Ac-GPC3 for Advanced Hepatocellular Carcinoma

Fosun Pharma's Henlius Strikes Deal with Sandoz for Global Rights to HLX13 Biosimilar
CompanyDeals

Fosun Pharma’s Henlius Strikes Deal with Sandoz for Global Rights to HLX13 Biosimilar

Show More